Subscribe To Our Free Newsletter |
Mankind Pharma Q3 Results: Cons PAT soars 60% YoY on robust all-round growth
Mankind Pharma Q3: Domestic revenue grew 20% YoY to Rs 2,400 crore, while exports more than doubled to Rs 207 crore. The strong domestic revenue was led by robust growth in the chronic portfolio, recovery in anti-infectives and strong growth in modern trade and hospital sales.